Google’s GV and allies double down on Forty Seven with their second $75M round
One of the most advanced, well-financed biotechs in the Bay Area just landed a $75 million B round to continue its clinical work.
Forty Seven …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
